Marta Garcia de Herreros
@MartaGdeH
Followers
154
Following
183
Statuses
205
Medical Oncologist, Hospital Clinic Barcelona, Genitourinary tumors
Barcelona
Joined May 2011
RT @jsoriamd: Cancer death rates in the U.S. have dropped 34% since 1991, averting over 4.5M deaths. However incidence continues to increas…
0
28
0
RT @begona_mellado: Motes gràcies Marc per tonart suport a la nostra recerca en las variants agressives de càncer de prostate, tesi dottora…
0
2
0
RT @OscarReigMD: @begona_mellado @hospitalclinic @MartaGdeH Crec que ha sigut una gran jornada on hem pogut aprendre i actualitzar-nos! Grà…
0
2
0
RT @urotoday: Tumor suppressor gene signature predicts early progression in #mHSPC. @MartaGdeH & @neerajaiims discuss clinical implications…
0
4
0
Excited to share the results of our study, now published in @EurUrolOpen! Tumor suppressor gene signature predicts early progression in #mHSPC patients. @begona_mellado @OscarReigMD @hospitalclinic
2
7
23
0
0
2
0
0
3
RT @elia_segui: Y no podría estar más orgullosa de mis dos R pequeños @jc_laguna_ @MartaGdeH que recibieron el premio @SEOM Futuro 2024 com…
0
8
0
RT @prat_aleix: Enorme orgullo por nuestros 2 residentes de Oncología Médica del Instituto del Cáncer @hospitalclinic, quienes han ganado l…
0
7
0
RT @OncobitesTv: 🔬 La Dra. @MartaGdeH del @clinicbarcelona presentó en #ESMO24 los resultados de un estudio que evalúa genes supresores tum…
0
2
0
RT @OscarReigMD: El proper 24 de Novembre es farà la Cursa Solidària Quatre Camins organitzada pel @cngranollers per recaudar fons per la #…
0
4
0
Thank you @urotoday and @neerajaiims for giving us the chance to discuss our work; a Tumor Suppressor Gene signature that identifies mHSPC patients with adverse outcomes and predicts development of aggressive forms of PC @begona_mellado
Tumor suppressor gene signature predicts early progression in #mHSPC. @MartaGdeH & @neerajaiims discuss clinical implications, the need for more frequent monitoring, patient counseling, and potential treatment strategies for pts with TSG-low signatures >
0
5
10
@urotoday @zklaassen_md @myESMO Thank you @urotoday for sharing our work! Joining efforts to find biomarkers in mHSPC that could help us to tailor better treatments @begona_mellado @OscarReigMD
0
0
2
RT @urotoday: Tumor suppressor gene signature predicts early progression in #mHSPC patients. Presentation by @MartaGdeH. #ESMO24 written co…
0
6
0
👉🏼 Check out our poster 496; High expression of androgen receptor-gene signature correlates with better prognosis in #mHSPC ✅, while #ARV7 is associated with adverse outcomes❌ @begona_mellado #ASCO24
0
4
17
RT @OscarReigMD: Avui hem fet la 3era sessió de l’Escola de Pacients amb Tumors Urològics! La Lorena Sánchez, nutricionista, ens ha parlat…
0
6
0
RT @prat_aleix: 🎉Felicidades equipazo de la Unidad de Soporte en Cáncer @hospitalclinic por este artículo publicado recientemente! Charac…
0
11
0
RT @begona_mellado: Happy to share our last paper. Lower expression of RB,PTEN and PT53 are associated to adverse clinical outcome in metas…
0
19
0
RT @OscarReigMD: 📣 Aquesta setmana organitzem el Curs C17 d’Actualització en Tumor Urològics en el que revisaren les últimes novetats de la…
0
8
0
Thrilled to share our work on PTEN expression in mHSPC: ⛔️ Shorter PFS and OS for pts with low PTEN expression treated with ADT +/- Docetaxel ➡️ No benefit with Docetaxel 📌 Check out the RNA-seq and functional analysis #ESMO23 @begona_mellado @OscarReigMD
0
3
19